Metabolic engineering of Streptomyces explomaris for increased production of the reverse antibiotic nybomycin.

Saved in:
Bibliographic Details
Title: Metabolic engineering of Streptomyces explomaris for increased production of the reverse antibiotic nybomycin.
Authors: Shu W; Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany., Stegmüller J; Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany., Rodriguez-Estevez M; Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany., Rückert-Reed C; CEBITEC, Bielefeld University, Bielefeld, Germany., Kalinowski J; CEBITEC, Bielefeld University, Bielefeld, Germany., Gromyko O; Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Lviv, Ukraine.; Microbial Culture Collection of Antibiotic Producers, Ivan Franko National University of Lviv, Lviv, Ukraine., Rebets Y; Explogen LLC, Lviv, Ukraine., Luzhetskyy A; Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany., Wittmann C; Institute of Systems Biotechnology, Saarland University, Saarbrücken, Germany. christoph.wittmann@uni-saarland.de.
Source: Microbial cell factories [Microb Cell Fact] 2025 Oct 30; Vol. 24 (1), pp. 227. Date of Electronic Publication: 2025 Oct 30.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101139812 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2859 (Electronic) Linking ISSN: 14752859 NLM ISO Abbreviation: Microb Cell Fact Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1475-2859
DOI:10.1186/s12934-025-02860-4